Complications of robot-assisted and laparoscopic partial nephrectomy

by S. A. Rakul, K. V. Pozdnyakov, R. A. Eloev
Published 2021-07-01

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer

by Lili Liao, Zongzhi Z Liu, Lauren Langbein, Weijia Cai, Eun-Ah Cho, Jie Na, Xiaohua Niu, Wei Jiang, Zhijiu Zhong, Wesley L Cai, Geetha Jagannathan, Essel Dulaimi, Joseph R Testa, Robert G Uzzo, Yuxin Wang, George R Stark, Jianxin Sun, Stephen Peiper, Yaomin Xu, Qin Yan, Haifeng Yang
Published 2018-10-01

Urinary Cyclophilin A as Marker of Tubular Cell Death and Kidney Injury

by Ramio Cabello, Miguel Fontecha-Barriuso, Diego Martin-Sanchez, Ana M. Lopez-Diaz, Susana Carrasco, Ignacio Mahillo, Carmen Gonzalez-Enguita, Maria D. Sanchez-Niño, Alberto Ortiz, Ana B. Sanz
Published 2021-02-01

Synchronous primary triple urogenital malignant tumors of kidney, prostate and bladder

by Hirofumi Kurose, Kosuke Ueda, Makoto Nakiri, Mitsunori Matsuo, Shigetaka Suekane, Tsukasa Igawa
Published 2020-11-01

The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer

by Kaamar Azijli, Kristy J Gotink, Henk M.W Verheul
Published 2016-01-01

Determinants of treatment in patients with stage IV renal cell carcinoma

by Christopher S. Hollenbeak, Eric W. Schaefer, Justin Doan, Jay D. Raman
Published 2019-11-01

Clinicians’ Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors

by Kristin Fahy, Lauren Augustine, Mats O Sanden, E. Robert Wassman
Published 2015-01-01

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy

by Moshe C. Ornstein, Laura S. Wood, Brian P. Hobbs, Kimberly D. Allman, Allison Martin, Michael Bevan, Timothy D. Gilligan, Jorge A. Garcia, Brian I. Rini
Published 2019-05-01

PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response

by Joseph Vento, Aditi Mulgaonkar, Layton Woolford, Kien Nham, Alana Christie, Aditya Bagrodia, Alberto Diaz de Leon, Raquibul Hannan, Isaac Bowman, Renee M. McKay, Payal Kapur, Guiyang Hao, Xiankai Sun, James Brugarolas
Published 2019-06-01

The ISUP system of staging, grading and classification of renal cell neoplasia

by Hemamali Samaratunga, Troy Gianduzzo, Brett Delahunt
Published 2014-07-01

Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population

by Jungyo Suh, Chang Wook Jeong, Seongmin Choi, Ja Hyeon Ku, Hyeon Hoe Kim, Kwangsoo Kim, Cheol Kwak
Published 2020-08-01

Automatic Extraction of the Pelvicalyceal System for Preoperative Planning of Minimally Invasive Procedures

by Heryan Katarzyna, Skalski Andrzej, Jakubowski Jacek, Drewniak Tomasz, Gajda Janusz
Published 2017-03-01

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

by Ghayathri Jeyakumar, Seongho Kim, Naresh Bumma, Craig Landry, Cynthia Silski, Stacey Suisham, Brenda Dickow, Elisabeth Heath, Joseph Fontana, Ulka Vaishampayan
Published 2017-10-01

A Rare Case of Solitary Kidney Metastasis following Primary Laryngeal Squamous Cell Carcinoma

by Sharon Del Vecchio, Robert Ellis, Kylie Gallagher, Keng Lim Ng, Li Ma, Geoffrey Strutton, Simon Wood
Published 2017-05-01

Evaluation of the Effects A2B Adenosine Receptor-Agonist (BAY 60–6583) in Induction of Apoptosis in ACHN Renal Cancer Cell Line

by Abdol-Vahab Shafiee, Mohammadreza Sharifi
Published 2018-04-01

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

by Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins
Published 2019-12-01

Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis

by Xiaobing Liu, Yaxing Hao, Wei Yu, Xia Yang, Xing Luo, Jiang Zhao, Jia Li, Xiaoyan Hu, Longkun Li
Published 2018-05-01

An Independent Validation of 2010 Tumor-Node-Metastasis Classification for Renal Cell Carcinoma: A Multi-center Study by the Urooncology Association of Turkey Renal Cancer-Study Gr...

by Tayyar Alp Özkan, Saadettin Eskiçorapçı, Özgür Yaycıoğlu, Bülent Akdoğan, Çağatay Göğüs, Ayhan Dirim, Cavit Can, Asıf Yıldırım, Haluk Özen, Levent Türkeri, Urooncology Association of Turkey Renal Cancer-Study Group
Published 2017-06-01

Liquid biopsy: a step forward towards precision medicine in urologic malignancies

by Ashley Di Meo, Jenni Bartlett, Yufeng Cheng, Maria D. Pasic, George M. Yousef
Published 2017-04-01

Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells

by Wohlrab C, Kuiper C, Vissers MCM, Phillips E, Robinson BA, Dachs GU
Published 2019-05-01